Evidence map›Paper›PMID 23746748›Full record

ArticleTrends in parasitology2013

Ahead of the curve: next generation estimators of drug resistance in malaria infections.

Nicole Mideo, David A Kennedy, Jane M Carlton, Jeffrey A Bailey, Jonathan J Juliano, Andrew F Read

Open access · greenAbstract read
In one paragraph

Article in Trends in parasitology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Drug resistance trends in Tuberculosis cases: Insights from a decade of surveillance data.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. UnderstandingiScience · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Temporal genomic analysis ofmedRxiv : the preprint server for health sciences · 2024
    Article
  7. Article
  8. Article
  9. UnderstandingFrontiers in immunology · 2019
    Review
  10. Article
  11. Frontiers in cellular and infection microbiology · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The biology of Plasmodium vivax explored through genomics.Annals of the New York Academy of Sciences · 2015
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Nicole MideoCenter for Infectious Disease Dynamics, Department of Biology, The Pennsylvania State University, University Park, PA 16802, USA. nlm12@psu.edu
David A Kennedy
Jane M Carlton
Jeffrey A Bailey
Jonathan J Juliano
Andrew F Read
Pennsylvania State University · USFogarty International Center · USNew York University · USUniversity of Massachusetts Chan Medical School · USUniversity of North Carolina at Chapel Hill · US

Funding

Using Next-Generation Genomics to Study Antimalarial Drug Resistance in IndiaU19AI089676 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARLTON, JANE M · 2010 to 2023
$22.6M
University of Massachusetts Center for Clinical and Translational ScienceUL1TR000161 · NCATS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LUZURIAGA, KATHERINE F · 2012 to 2015
$11.0M
Within Host Selection of P. falciparum Variants by Artemisinin Combination TherapR01AI089819 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JULIANO, JONATHAN J · 2010 to 2014
$1.9M
University of Massachusetts Center for Clinical and Translational ScienceKL2TR000160 · NCATS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LUZURIAGA, KATHERINE F · 2012 to 2014
$1.7M
NCATS NIH HHS KL2 TR000160NCATS NIH HHS UL1 TR000161NIAID NIH HHS R01 AI089819NIAID NIH HHS R01AI089819NIAID NIH HHS U19 AI089676NIAID NIH HHS U19AI089676
6 · The paper itself

Abstract

Drug resistance is a major obstacle to controlling infectious diseases. A key challenge is detecting the early signs of drug resistance when little is known about its genetic basis. Focusing on malaria parasites, we propose a way to do this. Newly developing or low level resistance at low frequency in patients can be detected through a phenotypic signature: individual parasite variants clearing more slowly following drug treatment. Harnessing the abundance and resolution of deep sequencing data, our 'selection differential' approach addresses some limitations of extant methods of resistance detection, should allow for the earliest detection of resistance in malaria or other multi-clone infections, and has the power to uncover the true scale of the drug resistance problem.

Indexed as

Drug ResistanceAnimalsAntimalarialsDrug MonitoringHigh-Throughput Nucleotide SequencingHumansMalariaPhenotypePlasmodium falciparumSequence Analysis, DNAAntimalarials

Identifiers

PMID23746748
PMCPMC3694767
OpenAlexW2008707977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.